Girancitug
Product Specifications
CAS Number
3024821-77-7
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis
Bioactivity
Girancitug is a humanized IgG1? monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
